Combining iron chelators with the nucleoside analog didanosine in anti-HIV therapy

Transfus Sci. 2000 Dec;23(3):249-50. doi: 10.1016/s0955-3886(00)00097-7.

Authors

N A Georgiou¹, T van der Bruggen, M Oudshoorn, H H Nottet, J J Marx, B S van Asbeck

Affiliation

¹ Department of Internal Medicine, University Medical Center Utrecht, Heidelberglaan 100, F02.126, 3584 CX Utrecht, The Netherlands.

PMID: 11099905
DOI: 10.1016/s0955-3886(00)00097-7

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-HIV Agents / pharmacology
Anti-HIV Agents / therapeutic use*
Didanosine / pharmacology
Didanosine / therapeutic use*
Drug Therapy, Combination
HIV Infections / drug therapy*
HIV-1 / drug effects*
Humans
Iron Chelating Agents / pharmacology
Iron Chelating Agents / therapeutic use*

Substances

Anti-HIV Agents
Iron Chelating Agents
Didanosine